Advances and challenges of chimeric antigen receptor T cell therapy in digestive system malignancies
{{output}}
Chimeric antigen receptor T cell therapy (CAR-T) has revolutionized the treatment of hematologic malignancies, but its success in solid tumors, particularly those of the digestive system, remains limited. Tumors of the gastrointestinal system, including gastri... ...